Company Filing History:
1 out of 52 
1 out of 5 Years Active: 2025
Title: Michela Consonni: Innovator in Hematological Treatments
Introduction
Michela Consonni is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of immunology, particularly in the development of T cell receptors (TCRs) for therapeutic applications. Her innovative work focuses on addressing hematological disorders through advanced biotechnological solutions.
Latest Patents
Michela Consonni holds a patent titled "TCR and uses thereof." This invention relates to a TCR or functional variant that has antigenic specificity for CD1c molecules associated with a self-lipid, preferably mLPA or a derivative thereof. The patent encompasses various applications, including relative polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, populations of cells, antibodies, and pharmaceutical compositions. The invention is particularly aimed at the treatment and/or prevention of hematological disorders.
Career Highlights
Throughout her career, Michela has worked with esteemed institutions such as Ospedale San Raffaele S.r.l. and Fondazione Centro San Raffaele. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Michela has collaborated with notable colleagues, including Giulia Casorati and Paolo Dellabona. These partnerships have enhanced her research and expanded the impact of her innovations in the medical community.
Conclusion
Michela Consonni is a trailblazer in the field of immunology, with her patent and collaborative efforts paving the way for advancements in the treatment of hematological disorders. Her contributions are vital to the ongoing development of innovative therapies.